Filtricine, Inc.

Filtricine, Inc. is a clinical stage biotechnology company focused on developing novel products for cancer management. We are backed by venture capital and located in the San Francisco Bay Area of California. We are developing an innovative way to help patients manage their cancers through our proprietary nutritional regimen of replacement meals. Our lead product is currently being investigated in clinical studies. This breakthrough technology emerged from research our founders performed at Stanford University.